Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes
March 6, 2023
Vector Laboratories, a portfolio company of Thompson Street Capital Partners, has acquired Click Chemistry Tools (Scottsdale, AZ) and Fluoroprobes to expand its manufacturing, bioconjugation and labeling capabilities. The add-on acquisitions, with terms undisclosed, are intended to accelerate commercialization of protein detection technologies and increase security of supply for biopharma, diagnostics and life-science customers.
- Buyers
- Vector Laboratories, Thompson Street Capital Partners
- Targets
- Click Chemistry Tools, Fluoroprobes
- Platforms
- Vector Laboratories
- Industry
- Biotechnology
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Thermo Fisher Scientific Acquires Olink Holding AB
July 10, 2024
Biotechnology
Thermo Fisher Scientific completed the acquisition of Olink Holding AB (publ) via a public cash tender offer at USD 26.00 per share/ADS, buying the proteomics company from shareholders including Summa Equity. The acquisition strengthens Thermo Fisher’s proteomics and protein-analysis capabilities, adding Olink’s high‑multiplex protein detection technology to its life‑science tools portfolio.
-
Vector Laboratories Acquires Quanta BioDesign
June 17, 2023
Biotechnology
Vector Laboratories has acquired Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG) technology, expanding Vector's bioconjugation linkers, dyes and payload delivery capabilities. The Plain City, Ohio-based company's dPEG reagents will broaden Vector's product portfolio and support life science and biopharma customers in therapeutic, diagnostic and research applications.
-
Pro-ficiency Acquires Fugitive Labs
July 12, 2022
Healthcare Services
Pro-ficiency has acquired all life-sciences intellectual property and the associated team of Fugitive Labs, bringing Fugitive's product development capabilities and team (led by Erik Guffrey) into Pro-ficiency's platform. The deal expands Pro-ficiency's product development capacity for clinical-trials simulation and performance-management products and is the company's first acquisition since being funded by NovaQuest Private Equity in 2021.
-
Thompson Street Capital Partners Acquires Vector Laboratories (Maravai Protein Detection Business)
September 7, 2021
Biotechnology
Thompson Street Capital Partners (TSCP), a St. Louis-based private equity firm, has acquired Vector Laboratories, the Protein Detection business unit of Maravai (NASDAQ: MRVI). Vector Laboratories is a manufacturer of labeling and visual detection reagents used in tissue-based protein detection for academic and corporate research; TSCP said the deal expands its life sciences capabilities and positions Vector for organic and strategic growth.
-
New England Biolabs Acquires Fluorogenics Limited
May 10, 2021
Biotechnology
New England Biolabs (NEB) has agreed to acquire Fluorogenics Limited (FGL), a UK-based lyophilization R&D and ISO 13485-certified service provider. FGL will become a wholly owned subsidiary of NEB as NEB integrates lyophilization capabilities into its OEM and Customized Solutions offering to better serve molecular and point-of-care diagnostics customers.
-
Discovery Life Sciences Acquires QualTek Molecular Laboratories
May 5, 2019
Healthcare Services
Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.